Nov 24 (Reuters) - U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter.
The report said that deliberations are still at an early stage following Johnson & Johnson's initial offer, and Actelion is working with an adviser to explore options. (bloom.bg/2g8UTe3)
Actelion shares have risen more than 13 percent this year, valuing it at about $17 billion.
Johnson & Johnson and Actelion were not immediately available for comment. (Reporting by Ankit Ajmera in Bengaluru; Editing by Bill Rigby)